In this issue of the Journal, Fuller et al. (1) showed in a large cohort of 140 people with prediabetes or well-controlled type 2 diabetes that 12 eggs/wk for 3 mo did not elevate LDL cholesterol compared with 2 eggs/wk. Does this completely exonerate eggs and mean no restriction is necessary for people with type 2 diabetes? It would be unwise to base decisions on one trial, especially given the epidemiology linking dietary cholesterol intake and cardiovascular disease (CVD) outcomes in people with type 2 diabetes (2-4) and even in those without type 2 diabetes (5). The participants in this study were overweight or obese with an average BMI (in kg/m 2 ) of 34. More than half were taking hypolipidemic medication, presumably statins. As a group, because of their high BMI they are likely to have 10-15% higher cholesterol synthesis and 20% lower cholesterol absorption than lean individuals without glucose intolerance (6), so they are less likely to respond to increased dietary cholesterol with an increase in either HDL or LDL cholesterol. How statins would influence the response to dietary cholesterol is not clear, but simvastatin has been shown to blunt the HDL and LDL response to dietary fat (7). However, doubling dietary cholesterol will increase the intestinal and lymphatic transit of cholesterol even if absorption is 20% lower, so one would expect to see cholesterol-enriched chylomicron remnants appearing in plasma, especially in hypertriglyceridemic persons, even if fasting variables do not change (8). Taggart et al. (9) performed a fat-feeding study with and without 1 g cholesterol in 10 people with type 2 diabetes and in 10 age-matched controls. Postprandial chylomicron cholesterol and triglycerides increased in both groups with cholesterol feeding but apolipoprotein B-48 concentrations were lower. VLDL apolipoprotein B-48 concentrations increased 10-fold in persons with type 2 diabetes compared with threefold in controls after the cholesterol-rich meals, whereas apolipoprotein B-100 was similar with both meals in the 2 groups. Cholesterol-enriched chylomicron and VLDL remnants are generally regarded as atherogenic (10); and postprandial triglyceride concentrations, which reflect these remnants at 4-6 h, are related to nonobstructive coronary artery disease as assessed by computed tomographic angiography (11).
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Where does this study stand in relation to the vast amount of data on cholesterol feeding in humans? Weggemans et al. (12) and HDL cholesterol, respectively. So HDL-cholesterol changes are of the same magnitude as in the meta-analysis, whereas totalcholesterol changes appear to be much weaker; however, given the very wide CI, it could contain the true population mean, which might be similar to the mean of the meta-analysis. The cause of the wide variation in response might include differences between individuals in weight, age, or statin usage and none of these factors were examined in this trial. Previous trials generally were in young, lean individuals who might be more consistent in their responses. In addition, this study measured lipids only once before and after the dietary intervention, whereas other studies improved precision by taking at least 2 and frequently 3 fasting lipid samples before and after the intervention.
The primary hypothesis of the study was that dietary cholesterol would elevate HDL cholesterol, and the assumption in the article's Introduction and Discussion is that such an elevation would be beneficial and reduce CVD risk on the basis of the epidemiology of HDL cholesterol and the possibly beneficial effect of fenofibrate on HDL cholesterol and on CVD events. However, saturated fat is the most powerful HDL-cholesterol elevator, and there is little evidence that this is beneficial. Freeliving persons with low HDL cholesterol while consuming a high-fat Western diet may have a genetic predisposition to faulty HDL-cholesterol and triglyceride metabolism, and it is this factor that may link HDL cholesterol to CVD risk (13) rather than the HDL cholesterol per se. In the one previous study in type 2 diabetes the combination of weight loss and dietary cholesterol elevated HDL cholesterol compared with weight loss alone, but LDL changes were not different (14) .
Shin et al. (2) showed that consumption of .7 eggs/wk was associated with 69% more CVD events in men and women with type 2 diabetes. Rong et al. (3) found the risk of heart attack was 50% higher when comparing the highest with the lowest intakes of eggs in 4 studies of populations with diabetes, whereas Djoussé et al. (5) found that the consumption of 7 eggs/wk was associated with incident heart failure in US physicians. Given these data and the fact that coronary risk is not fully captured by fasting lipids, caution is needed in recommending daily egg consumption in people with type 2 diabetes. Similar caution about making conclusions on the basis of amount and quality of the intervention data has been expressed by others (5).
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